Page 92 - Sohini Das

Serum Institute looking at bilateral deals to supply Covishield vaccine

To raise manufacturing capacity by 30% over next 2 months from present 2.4 mn doses

Dr Reddy's, Zuventus get nod to conduct Covid-19 trials on repurposed drugs

NeuroRx and Relief Therapeutics have partnered to develop a drug called RLF-100 that has anti-inflammatory and anti-cytokine activity properties.

Wockhardt, IIL discuss manufacturing tie-up with US vaccine major Moderna

Around November, IIL had indicated that it was open to discussions with the US major.

Indemnity clause: Serum Institute of India knocks on govt door again

SII Chief Executive Officer Adar Poonawalla earlier indicated legal indemnity was required to ensure that the vaccination drive could be completed smoothly

Nasal vaccine: Bharat Bio told to submit efficacy data from Phase-3 trials

India may start vaccine exports as soon as today

Exports of Covid-19 vaccines may start in 2 weeks: SII CEO Adar Poonawalla

The vaccine manufacturer is making preparations and working on necessary regulatory protocols

States rush to complete frontline worker surveys ahead of vaccination drive

Also wait for instructions from the Centre on the second phase of the drive

Centre to track casual links to determine Covid-19 vaccine liability

As for Serum Institute of India's Covishield approval, the drug regulator has mentioned in conditions to be met that the firm has to submit an India-specific risk management plan

Covid-19 vaccine makers divided on indemnity ahead of vaccination drive

Govt unlikely to take a shot at Covid-19 vaccine liability, say legal experts

Bharat Biotech signs deal with Brazilian wholesaler to supply Covaxin

Quantum of doses to be exported not known

Both Serum's Covishield, Bharat Bio's Covaxin vaccines cost same to Centre

People can't choose between Covishield & Covaxin, says govt; vaccine to take effect two weeks after the second dose

Pfizer compiling data to answer DCGI queries on coronavirus vaccine

Drug major clarifies it could not present itself before the SEC because of short notice and time zone issues

Govt inks pact, first consignment of Covid-19 vaccines to fly today

Serum to supply 11 mn doses at Rs 200 each initially

From factory to front line, all roads lead to Covid-19 vaccine roll-out

According to sources, a contract may be signed between the government and the vaccine makers on Monday, and the first batch of vaccinations will be done using Serum Institute's (SII's) Covishield

Activists raise red flag around Bharat Biotech's Covaxin trial in Bhopal

Write to PM and health minister, call for an independent inquiry

Bright outlook: Sun Pharma to Cipla, drug firms set for Q3 health boost

Analysts expect earnings growth to be in the range of 30-40 per cent for drug firms owing to both domestic recovery as well as strong export opportunities

V G Somani: The DCGI chief, a man known by his actions, 'not of words'

To the media, Somani may be a man of few words but among peers he's known for quick responses

PM Modi meet with CMs to kickstart mega Covid-19 vaccination drive

The government is in the final stages of due diligence to ink a supply deal with Serum Institute of India and Bharat Biotech, which have got approval for emergency use of their vaccines

Serum Institute may supply around 400 million more doses to Gavi-Covax

Serum Institute already has two deals of 100 million each to supply the Oxford-AstraZeneca and the Novavax vaccine to Gavi-Covax at $3 per dose

Airlines get ready for Covid-19 vaccine journey ahead of inoculation drive

Government has asked airlines to get ready to transport 30 tonnes of vaccines immediately